M&A in the AI sector is redefining deal risk, especially when sensitive data is involved. As AI companies power breakthroughs in biotech, healthcare, defense, and critical infrastructure, the stakes for companies acquiring...more
5/22/2025
/ Acquisitions ,
Artificial Intelligence ,
Biotechnology ,
Data Privacy ,
Data Security ,
Due Diligence ,
Food and Drug Administration (FDA) ,
Healthcare ,
Mergers ,
Privacy Laws ,
Regulatory Requirements ,
Research and Development ,
Technology
Is your M&A target a company that develops or uses artificial intelligence (“AI”) tools? AI, and generative AI technologies specifically, are powerful business tools but present novel legal issues in the context of M&A...more
When participating in an M&A process involving a video game company, whether you are on the sell-side or the buy-side, there are certain key terms that are included in industry standard commercial agreements that the parties...more